Viewing data from:

AQUAMEPHYTON

NDA

PHYTONADIONE | N012223 | PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC

2 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain10 active DMFs

8 active API suppliers hold Drug Master Files for this ingredient.

BIOPHORE INDIA PHARMACEUTICALS PVT LTDPHYTONADIONE

DMF 264472012

G AND A ASSOC INCPHYTONADIONE USP, NON STERILE, BULK DRUG

DMF 266542012

BIOPHORE INDIA PHARMACEUTICALS PVT LTDPHYTONADIONE ROUTE-B

DMF 278052013

MSN LABORATORIES PRIVATE LTDPHYTONADIONE USP [ROUTE CODE "HN"]

DMF 296692015

ENALTEC LABS PRIVATE LTDPHYTONADIONE USP

DMF 301762016

EMCURE PHARMACEUTICALS LTDPHYTONADIONE USP

DMF 307752016

NAVINTA LLCPHYTONADIONE USP (PROCESS A)

DMF 309102016

ENALTEC LABS PRIVATE LTDPHYTONADIONE USP

DMF 329472018

AMPHASTAR NANJING PHARMACEUTICALS INCPHYTONADIONE USP

DMF 379532023

ANHUI WANHE PHARMACEUTICAL CO LTDPHYTONADIONE (VITAMIN K1)

DMF 428962025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

5 letters from Drugs@FDA

Date	Submission	Document
Mar 15, 2018	SUPPL -41	View Letter (PDF)
May 30, 2017	SUPPL -40	View Letter (PDF)
Jun 8, 2003	SUPPL -39	View Letter (PDF)
Mar 10, 2003	SUPPL -38	View Letter (PDF)
May 18, 2001	SUPPL -36	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RLD

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RLD

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982